Impact of the Affordability of Novel Agents in Patients With Multiple Myeloma: Real-World Data of Current Clinical Practice in Mexico

Cancer - United States
doi 10.1002/cncr.31305
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Value of Novel Agents and Intensive Therapy for Patients With Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2013English

Real World Data of the Impact of First Cycle Daratumumab on Multiple Myeloma and AL Amyloidosis Services

British Journal of Haematology
Hematology
2017English

Pcn113 - Evaluating the Economic Impact of Novel Agents for Treating Multiple Myeloma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in France

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2019English

Mo1 - Combining Internally Valid Trial Evidence With Generalizable Real-World Data: Insights Into Effects, Costs, and Cost-Effectiveness of Novel Treatment Sequences in Patients With Multiple Myeloma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Bortezomib: The Evidence of Its Clinical Impact in Multiple Myeloma

Core Evidence
MedicineReviewsReferencesPharmacology
2006English

Clinical Impact of Serum Soluble SLAMF7 in Multiple Myeloma

Oncotarget
Oncology
2018English

Persistent Dyslipidemia in Statin-Treated Patients: Russian Real-World Clinical Practice Data (Russian Part of the DYSIS Study)

Cardiovascular Therapy and Prevention (Russian Federation)
Cardiovascular MedicineCardiology
2012English

The USE MODIFIED RISK STRATIFICATION mSMART 3.0 IN REAL CLINIC PRACTICE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy